Abstract

Journal of the European Academy of Dermatology and VenereologyAccepted Articles LETTER TO THE EDITOR Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: a phase II randomized, double-blind, placebo-controlled pilot trial C. Cox, C. Cox orcid.org/0000-0001-7730-3702 The University of Queensland, Frazer Institute, Dermatology Research Centre, Experimental Dermatology Group, Brisbane, Australia Princess Alexandra Hospital, Department of Dermatology, Brisbane, Australia Queensland Institute of Dermatology, Brisbane, AustraliaSearch for more papers by this authorK. Fry, K. Fry The University of Queensland, Frazer Institute, Dermatology Research Centre, Experimental Dermatology Group, Brisbane, AustraliaSearch for more papers by this authorY. Sivakumaran, Y. Sivakumaran Princess Alexandra Hospital, Department of Vascular Surgery, Brisbane, AustraliaSearch for more papers by this authorL. Spelman, L. Spelman Queensland Institute of Dermatology, Brisbane, AustraliaSearch for more papers by this authorK. Khosrotehrani, Corresponding Author K. Khosrotehrani k.khosrotehrani@uq.edu.au orcid.org/0000-0002-6406-4076 The University of Queensland, Frazer Institute, Dermatology Research Centre, Experimental Dermatology Group, Brisbane, Australia Princess Alexandra Hospital, Department of Dermatology, Brisbane, Australia Queensland Institute of Dermatology, Brisbane, Australia Correspondence Prof Kiarash Khosrotehrani, MD PhD FACD The University of Queensland, Frazer Institute, Translational Research Institute 37 Kent Street, Woolloongabba 4102 QLD, Australia. Email: k.khosrotehrani@uq.edu.auSearch for more papers by this author C. Cox, C. Cox orcid.org/0000-0001-7730-3702 The University of Queensland, Frazer Institute, Dermatology Research Centre, Experimental Dermatology Group, Brisbane, Australia Princess Alexandra Hospital, Department of Dermatology, Brisbane, Australia Queensland Institute of Dermatology, Brisbane, AustraliaSearch for more papers by this authorK. Fry, K. Fry The University of Queensland, Frazer Institute, Dermatology Research Centre, Experimental Dermatology Group, Brisbane, AustraliaSearch for more papers by this authorY. Sivakumaran, Y. Sivakumaran Princess Alexandra Hospital, Department of Vascular Surgery, Brisbane, AustraliaSearch for more papers by this authorL. Spelman, L. Spelman Queensland Institute of Dermatology, Brisbane, AustraliaSearch for more papers by this authorK. Khosrotehrani, Corresponding Author K. Khosrotehrani k.khosrotehrani@uq.edu.au orcid.org/0000-0002-6406-4076 The University of Queensland, Frazer Institute, Dermatology Research Centre, Experimental Dermatology Group, Brisbane, Australia Princess Alexandra Hospital, Department of Dermatology, Brisbane, Australia Queensland Institute of Dermatology, Brisbane, Australia Correspondence Prof Kiarash Khosrotehrani, MD PhD FACD The University of Queensland, Frazer Institute, Translational Research Institute 37 Kent Street, Woolloongabba 4102 QLD, Australia. Email: k.khosrotehrani@uq.edu.auSearch for more papers by this author First published: 13 March 2023 https://doi.org/10.1111/jdv.19041 This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/jdv.19041. AboutPDF ToolsExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Accepted ArticlesAccepted, unedited articles published online and citable. The final edited and typeset version of record will appear in the future. RelatedInformation

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call